Global Alcoholic Hepatiti Drug Market Report 2021 with Top Countries Data And Covid-19 Analysis Overview By Industry Size, Share, Trends, Growth Factors and Leading Players Research and forecast to 2024
The Express Wire · 1d ago
Global G Protein Coupled Bile Acid Receptor 1 Market Outlook, Industry Analysis and Prospect 2021-2026
Heraldkeepers · 1d ago
Non-alcoholic Fatty Liver Disease (NAFLD) & NASH Market Report 2021-2031
New York, April 15, Apr 15, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, April 15, 2021 (GLOBE NEWSWIRE) -- announces the release of the...
GlobeNewswire · 1d ago
Global Alcoholic Hepatiti Drug Market Outlook, Industry Analysis and Prospect 2021-2026
Apr 15, 2021 (Heraldkeepers) -- The Alcoholic Hepatiti Drug market report provides a detailed analysis of global market size, regional and country-level...
Heraldkeepers · 2d ago
Global Ocaliva Market Outlook, Industry Analysis and Prospect 2021
Heraldkeepers · 4d ago
Global Obeticholic Acid Drug Market Outlook, Industry Analysis and Prospect 2021
Apr 13, 2021 (Heraldkeepers) -- The research report includes specific segments by region (country), by company, by Type and by Application. This study...
Heraldkeepers · 4d ago
Obeticholic Acid Drug Market Share, Size, Growth, Business Demand, Global Market Analysis, Trends, Research and Forecast to 2021-2025
Apr 08, 2021 (The Expresswire) -- Global "Obeticholic Acid Drug Market" (2021) thoroughly scrutinizes the effects of a wide range of factors impacting the...
The Express Wire · 04/08 07:34
G Protein Coupled Bile Acid Receptor 1 Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2027
Apr 06, 2021 (Market Insight Reports) -- CANADA - QYResearchMedical recently added a research report, G Protein Coupled Bile Acid Receptor 1 market – global...
Market Insight Reports · 04/06 19:21
Non-Alcoholic SteatoHepatitis (NASH) Market Size to be Worth USD 54 Billion Growing at 58.6% CAGR till 2027; Industry Revenue, Statistics, Forecast by Reports And Data
Apr 05, 2021 (Market Insight Reports) -- The global non-alcoholic steatohepatitis (NASH) market was valued at USD 2.94 billion in 2019 and is projected to...
Market Insight Reports · 04/05 11:00
Global Primary Biliary Cirrhosis Drug Market 2021-2027 with Top Countries Data Industry Size, Share, Business Growth, Revenue, Trends, Market Demand Penetration and Forecast | With Covid-19 Analysis
The Express Wire · 04/05 05:03
Global Obeticholic Acid Market Size, Share, Value, and Competitive Landscape 2024
Apr 02, 2021 (Heraldkeepers) -- beticholic acid (OCA), sold under the brand name Ocaliva, is a semi-synthetic bile acid analogue which has the chemical...
Heraldkeepers · 04/02 05:35
Intercept Pharmaceuticals Stock Is Believed To Be Possible Value Trap
GuruFocus News · 04/01 22:23
G Protein Coupled Bile Acid Receptor 1 Global Market Growth, Status and Outlook Research Report 2021
Mar 30, 2021 (Heraldkeepers) -- Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):INT-777RDX-98940S-0071261Others GET...
Heraldkeepers · 03/30 07:28
Intercept (ICPT) Up 0.4% Since Last Earnings Report: Can It Continue? · 03/27 17:29
Primary Biliary Cirrhosis Drug Market Type , Application and Region - Global Trends and Forecast to 2027 By Ameco Research
pune, India, Thu, 25 Mar 2021 01:40:00 / Comserve Inc. / -- The global Primary Biliary Cirrhosis Drug market is segmented by company, region (country), by...
Comserve · 03/25 05:42
Strong Insider Buying Could Indicate a Bottom in These 2 Stocks
Every investor knows that the path toward profits lies in buying low and selling high. That’s a basic precept of any economic trading system. The trick, however, is recognizing when the stock is low enough to buy in. The prime moment to buy is when the sto...
TipRanks · 03/25 01:47
Nonalcoholic Steatohepatitis (NASH) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Mar 24, 2021 (Market Insight Reports) -- The Global Nonalcoholic Steatohepatitis (NASH) Market is estimated to register a CAGR of over 52.9% during the...
Market Insight Reports · 03/24 12:00
Webull provides a variety of real-time ICPT stock news. You can receive the latest news about Intercept through multiple platforms. This information may help you make smarter investment decisions.
About ICPT
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). In addition to OCA, it is developing other bile acid analog compounds targeting FXR and a second dedicated bile acid receptor called TGR5, which is a target of interest for the treatment of type 2 diabetes and other gastrointestinal indications. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.